Brain-derived neurotrophic factor promotes cochlear spiral ganglion cell survival and function in deafened, developing cats

Journal of Comparative Neurology

Volumn 519, Issue 8, 2011, Pages 1526-1545

  Leake, Patricia A ^a   Hradek, Gary T ^a   Hetherington, Alexander M ^a   Stakhovskaya, Olga ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Auditory deprivation; Auditory nerve; BDNF; Cochlear implant; Cochlear spiral ganglion; Electrical stimulation; Neonatal deafness; Neurotrophins; Primary afferents

Indexed keywords

MYELIN; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CELL DENSITY; CELL FUNCTION; CELL GROWTH; CELL SURVIVAL; COCHLEA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; EVOKED BRAIN STEM AUDITORY RESPONSE; HEARING IMPAIRMENT; MYELINATED NERVE; NERVE CELL; NERVE CELL DEGENERATION; NERVE SPROUTING; NEWBORN; NONHUMAN; PERILYMPH; PRIORITY JOURNAL; RADIAL NERVE; RAT; SCALA TYMPANI; SPIRAL GANGLION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATS; CELL SURVIVAL; DEAFNESS; HUMANS; NEURONS; SPIRAL GANGLION;

EID: 79954569196     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.22582     Document Type: Article

References (109)

1. Agterberg MJ, Versnel H, de Groot JC, Smoorenburg GF, Albers FW, Klis SF. 2008. Morphological changes in spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs. Hear Res 244: 25-34.
2. Agterberg MJ, Versnel H, van Dijk LM, de Groot JC, Klis SF. 2009. Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs. J Assoc Res Otolaryngol 10: 355-367.
3. Alam SA, Robinson BK, Huang J, Green SH. 2010. Prosurvival and proapoptotic intracellular signaling in rat spiral ganglion neurons in vivo after the loss of hair cells. J Comp Neurol (in press).
4. Araki S, Atsushi K, Seldon HL, Shepherd RK, Funasaka S, Clark GM. 1998. Effects of chronic electrical stimulation on spiral ganglion neuron survival and size in deafened kittens. Laryngoscope 108: 687-695.
5. Chikar JA, Colesa DJ, Swiderski DL, Di Polo A, Raphael Y, Pfingst BE. 2008. Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear Res 245: 24-34.
6. Coco A, Epp SB, Fallon JB, Xu J, Millard RE, Shepherd RK. 2007. Does cochlear implantation and electrical stimulation affect residual hair cells and spiral ganglion neurons? Hear Res 225: 60-70.
7. Dettman SJ, Pinder D, Briggs RJ, Dowell RC, Leigh JR. 2007. Communication development in children who receive the cochlear implant younger than 12 months: risks versus benefits. Ear Hear 28( Suppl 2): 11S-18S.
8. Eggermont JJ, Bock GR. editors. 1986.Critical periods in auditory development. Acta Otolaryngol Suppl 429: 1-64.
9. Elverland HH, Mair IW. 1980. Hereditary deafness in the cat. An electron microscopic study of the spiral ganglion. Acta Otolaryngol 90: 360-369.
10. Endo T, Nakagawa T, Kita T, Iguchi F, Kim TS, Tamura T, Iwai K, Tabata Y, Ito J. 2005. Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 115: 2016-2020.
11. Ernfors P, Duan ML, El-Shamy WM, Banlon B. 1996. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat Med 2: 463-467.
12. Farinas I, Jones KR, Tessarollo L, Vigers AJ, Kirstein M, deCaprona DC, Voppola V, Backus C, Reichardt LF, Fritzsch B. 2001. Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J Neurosci 21: 6170-6180.
13. Fraysse B, Macias AR, Sterkers O, Burdo S, Ramsden R, Dequine O, Klenzner T, Lenarz T, Rodriguez MM, Von Wallenberg E, James C. 2006. Residual hearing conservation and electroacoustic stimulation with the nucleus 24 contour advance cochlear implant. Otol Neurotol 27: 624-633.
14. Fritzsch B, Pirvola U, Ylikoski J. 1999. Making and breaking the innervation of the ear: neurotrophic support during ear development and its clinical implications. Cell Tissue Res 295: 369-382.
15. Fritzsch B, Tessarollo L, Coppola V, Reichardt LF. 2004. Neurotrophins in the ear: their roles in sensory neuron survival and guidance. Prog Brain Res 146: 265-278.
16. Fritzsch B, Pauley S, Matei V, Katz DM, Xiang M, Tessarollo L. 2005. Mutant mice reveal the molecular and cellular basis for specific sensory connections to inner ear epithelia and primary nuclei of the brain. Hear Res 206: 52-63.
17. Gao W-Q, Zheng JL, Karihaloo M. 1995. Neurotrophin-4/5 (NT-4/5) and brain-derived neurotrophic factor act at later stages of cerebellar granule cell differentiatiation. J Neurosci 15: 2656-2667.
18. Geers AE. 2004. Speech, language and relating skills after early cochlear implantation. Arch Otolaryngol Head Neck Surg 130: 634-638.
19. Gillespie LN, Shepherd RK. 2005. Clilnical application of neurotrophic factors: the potential for primary auditory neuron protection. Eur J Neurosci 22: 2123-2133.
20. Glueckert R, Bitsche M, Miller JM, Zhu Y, Prieskorn DM, Altschuler RA, Schrott-Fischer A. 2008. Deafferentation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. J Comp Neurol 507: 1602-1621.
21. Hansen MR, Zha X-M, Bok J, Green SH. 2001. Multiple distinct signal pathways, including an autocrine neurotrophic mechanism contribute to the survival-promoting effect of depolarization on spiral ganglion neurons in vitro. J. Neuroscience 21: 2256-2267.
22. 2+/calmodulin-dependent protein kinases II and IV both promote survival but differ in their effects on axon growth in spiral ganglion neurons. J Neurosci Res 72: 169-184.
23. Harris JA, Rubel EW. 2006. Afferent regulation of neuron number in the cochlear nucleus: cellular and molecular analyses of a critical period. Hear Res 216-217: 127-137.
24. Hartmann R, Topp G, Klinke R. 1984. Electrical stimulation of the cat cochlea: Discharge pattern of single auditory fibers. Adv Audiol 1: 18-29.
25. Hartshorn DO, Miller JM, Altschuler RA. 1991. Protective effect of electrical stimulation in the deafened guinea pig cochlea. Otolaryngol Head Neck Surg 104: 311-319.
26. i within a set range. J Neurosci 17: 1959-1970.
27. Hochmair I, Nopp P, Jolly C, Schmidt M, Schößer H, Garnham C, Anderson I. 2006. MED-EL cochlear implants: state of the art and a glimpse into the future. Trends Amplification 10: 201-220.
28. James CJ, Fraysse B, Deguine O, Lenarz T, Mawman D, Ramos A, Ramsden R, Sterkers O. 2006. Combined electroacoustic stimulation in conventional candidates for cochlear implantation. Audiol Neurootol 11( Suppl 1): 57-62.
29. Kanzaki S, Stover T, Kawamoto K, Priskorn DM, Altschuler RA, Miller JM, Raphael Y. 2002. GDNF and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J.Comp Neurol 454: 450-360.
30. Kiang NYS, Rho JM, Northrop CC, Liberman MC, Ryugo DK. 1982. Hair cell innervation by spiral ganglion cells in adult cats. Science 217: 129-177.
31. Kiang NYS, Liberman MC, Gage JS, Northrop CC, Dodds LW, Oliver ME. 1984. Afferent innnervation of the mammalian cochlea. In: Bolis L, Deynes RD, Maddrel SHP, editors. Comparative physiology of sensory systems. New York: Cambridge University Press. p 143-161.
32. Kitzes L. 1996. Anatomical and physiological changes in the brainstem induced by neonatal ablation of the cochlea. In: Salvi RJ, Henderson D, editors. Auditory system plasticity and regeneration. New York: Thieme Medical Publishers. p 256-274.
33. Kitzes LM, Kageyama GH, Semple MN, Kil J. 1995. Development of ectopic projections from the ventral cochlear nucleus to the superior olivary complex induced by neonatal ablation of the contralateral cochlea. J Comp Neurol 353: 341-363.
34. Korsching S. 1993. The neurotrophic factor concept: a reexamination. J Neurosci 13: 2739-2748.
35. Leake PA, Hradek GT. 1988. Cochlear pathology of long term neomycin induced deafness in cats. Hear Res 33: 11-34.
36. Leake PA, Hradek GT, Snyder RL, Rebscher SJ. 1991. Chronic intracochlear electrical stimulation induces selective survival of spiral ganglion cells in neonatally deafened cats. Hear Res 54: 251-271.
37. Leake PA, Snyder RL, Hradek GT, Rebscher SJ. 1992. Chronic intracochlear electrical stimulation in neonatally deafened cats: effects of intensity and stimulating electrode location. Hear Res 64: 99-117.
38. Leake PA, Snyder RL, Hradek GT, Rebscher SJ. 1995. Consequences of chronic extracochlear electrical stimulation in neonatally deafened cats. Hear Res 82: 65-80.
39. Leake PA, Kuntz AL, Moore CM and Chambers PL. 1997. Cochlear pathology induced by aminoglycoside ototoxicity during postnatal maturation in cats. Hear Res 113: 117-132.
40. Leake PA, Hradek GT, Snyder RL. 1999. Chronic electrical stimulation by a cochlear implant promotes survival of spiral ganglion neurons in neonatally deafened cats. J Comp Neurol 412: 543-562.
41. Leake PA, Hradek GT, Vollmer M, Rebscher SJ. 2007. Neurotrophic effects of GM1 ganglioside and electrical stimulation on cochlear spiral ganglion neurons in cats deafened as neonates. J Comp Neurol 501: 837-853.
42. Leake PA, Stakhovskaya O, Hradek GT. 2008. Factors influencing neurotrophic effects of electrical stimulation in the deafened, developing auditory system. Hear Res 242: 86-99.
43. Lefebvre PP, Van de Water TR, Weber T, Rogister B, Moonen G. 1991. Browth factor interactions in cultures of dissociated adult acoustic ganglia: neuronotrophic effects. Brain Res 567: 306-312.
44. Lefebvre PP, Malgrange B, Staecker H, Moghadass M, Van de Water TR, Moonen G. 1994. Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. Neuroreport 5: 865-868.
45. Li L, Parkins CW, Webster DB. 1999. Does electrical stimulation of deaf cochleae prevent spiral ganglion degeneration? Hear Res 133: 27-39.
46. Liberman MC, Kiang NY. 1978. Acoustic trauma in cats. Cochlear pathology and auditory-nerve activity. Acta Otolaryngol Suppl 358: 1-63.
47. Liberman MC, Dodds LW, Pierce S. 1990. Afferent and efferent innervation of the cat cochlea: quantitative analysis with light and electron microscopy. J Comp Neurol 301: 443-460.
48. Lousteau RJ. 1987. Increased spiral ganglion cell survival in electrically stimulated, deafened guinea pig cochleae. Laryngoscope 97: 836-842.
49. Malgrange B, Lefebvre PP, Martin D, Staecker H, Van de Water TR, Moonen G. 1996. NT-3 has a tropic effect on process outgrowth by postnatal auditory neurones in vitro. Neuroreport 7: 2495-2499.
50. Maruyama J, Miller JM, Ulfendahl M. 2008. Glial cell line-derived neurotrophic factor and antioxidants preserve the electrical responsiveness of the spiral ganglion neurons after experimentally induced deafness. Neurobiol Dis 29: 14-21.
51. McGuinness SL, Shepherd RK. 2005. Exogenous BDNF rescues rat spiral ganglion neurons in vivo. Otol Neurotol 26: 1064-1072.
52. Miller AL. 2001. Effects of chronic stimulation on auditory nerve survival in ototoxically deafened animals. Hear Res 151: 1-14.
53. Miller JM, Altschuler RA. 1995. Effectiveness of different electrical stimulation conditions in preservation of spiral ganglion cells following deafness. Ann Otol Rhinol Laryngol 166: 57-60.
54. Miller JM, Chi DH, O'Keefe LJ, Kruszka P, Raphael Y, Altschuler RA. 1997. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 15: 631-643.
55. Miller JM, Le Prell CG, Prieskorn DM, Wys NL, Altschuler RA. 2007. Delayed neurotrophin treatment following deafness rescues spiral ganglion cells from death and promotes regrowth of auditory nerve peripheral processes: effects of brain-derived neurotrophic factor and fibroblast growth factor. J Neurosci Res 85: 1959-1969.
56. Mitchell A, Miller JM, Finger PA, Heller JW, Raphael Y, Altschuler RA. 1997. Effects of chronic high-rate electrical stimulation on the cochlea and eighth nerve in the deafened guinea pig. Hear Res 105: 30-43.
57. Moore DR, Kitzes LM. 1985. Projections from the cochlear nucleus to the inferior colliculus in normal and neonatally cochlea-ablated gerbils. J Comp Neurol 240: 180-195.
58. Moore DR, Kowalchuk NE. 1988. Auditory brainstem of the ferret: effects of unilateral cochlear lesions in cochlear nucleus volume and projections to the inferior colliculus. J Comp Neurol 272: 503-515.
59. Mou K, Hunsberger CL, Cleary JM, Davis RL. 1997. Synergistic effects of BDNF and NT-3 on postnatal spiral ganglion neurons. J Comp Neurol. 386: 529-539.
60. Mou K, Adamson CL, Davis RL. 1998. Time-dependence and cell-type specificity of synergistic neurotrophin actions on spiral ganglion neurons. J Comp Neurol 402: 129-139.
61. Mouton PR. 2002. Principles and practices of unbiased stereology: an introduction for bioscientists. Baltimore: The Johns Hopkins University Press.
62. Nakaizumi T, Kawamoto K, Minoda R, Raphael Y. 2004. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol 9: 135-143.
63. Nicholas JG, Geers AE, 2007. Will they catch up? The role of age at cochlear implantation in the spoken language development of children with severe to profound hearing loss. J Speech Lang Hear Res 50: 1048-1062.
64. Niparko JK, Finger PA. 1997. Cochlear nucleus cell size changes in the Dalmatian: model of congenital deafness. Otolaryngol Head Neck Surg 117: 229-235.
65. Nordeen KW, Killackey HP, Kitzes LM. 1983. Ascending projections to the inferior colliculus following unilateral cochlear ablation in the neonatal gerbil, meriones unguiculatus. J Comp Neurol 214: 144-153.
66. Paasche G, Gibson P, Averbeck T, Becker H, Lenarz T, Stover T. 2003. Technical report: modification of a cochlear implant electrode for drug delivery to the inner ear. Otol Neurotol 24: 222-227.
67. Pettingill LN, Minter RL, Shepherd RK. 2008. Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro. Neuroscience 152: 821-828.
68. Rebscher SJ, Hetherington AM, Snyder RL, Leake PA Bonham BH. 2007. Design and fabrication of multichannel cochlear implants for animal research. J Neurosci Methods 166: 1-12.
69. Rejali D, Lee VA, Abrashkin KA, Humayun N, Swiderski DL, Raphael Y. 2007. Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear Res 228: 180-187.
70. Richardson RT, Wise AK, Andrew JK, O'Leary SJ. 2008. Novel drug delivery systems for inner ear protection and regeneration after hearing loss [review]. Expert Opin Drug Deliv 1059-1076.
71. Richardson RT, Wise AK, Thompson BC, Flynn BO, Atkinson PJ, Fretwell NJ, Fallon JB, Wallace GG, Shepherd RK, Clark GM, O'Leary SJ. 2009. Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 30: 2614-2624.
72. Roehm PC, Hansen MR. 2005. Strategies to preserve or regenerate spiral ganglion neurons. Curr Opin Otolaryngol Head Neck Surg 13: 295-300.
73. Romand R, Romand M-R. 1986. Perinatal growth of spiral ganglion cells in the kitten. Hear Res 21: 161-165.
74. Romand R, Romand M-R. 1990. Development of spiral ganglion cells in mammalian cochlea. J Elec Microsc Techniq 15: 144-154.
75. Rubel EW, Fritzsch B. 2002. Auditory system development: primary auditory neurons and their targets. Annu Rev Neurosci 25: 51-101.
76. Rubens RJ. 1986. Unsolved issues around critical periods with emphasis on clinical application. Acta Otolaryngol Suppl 429: 61-64.
77. Rubens RJ, Rapin I. 1980. Plasticity of the developing auditory system. Ann Otol Rhinol Laryngol 89: 303-311.
78. Russell RA, Moore DR. 1995. Afferent reorganization within the superior olivary complex of the gerbil: development and induction by neonatal unilateral cochlear removal. J Comp Neurol 352: 607-625.
79. Scheper V, Paasche G, Miller JM, Warnecke A, Berkingali N, Lenarz T, Stover T. 2009. Effects of delayed treatment with combined GDNF and continuous electrical stimulation on spiral ganglion survival in deafened guinea pigs. J Neurosci Res 87: 1389-1399.
80. Schindler RA, Gladstone HB, Scott N, Hradek GT, Williams H, Shah SB. 1995. Enhanced preservation of the auditory nerve following cochlear perfusion with nerve growth factor. Am J Otol 16: 304-309.
81. Shah SB, Gladstone HB, Williams H, Hradek GT, Schindler RA. 1995. An extended study: protective effects of nerve growth factor in neomycin-induced auditory neural degeneration. Am J Otol 16: 310-314.
82. Shepherd RK, Javel E. 1997. Electrical stimulation of the auditory nerve. I. Correlation of physiological responses with cochlear status. Hear Res 108: 112-144.
83. Shepherd RK, Xu J. 2002. A multichannel scala tympani electrode array incorporating a drug delivery system for chronic intracochlear infusion. Hear Res 172: 92-98.
84. Shepherd RK, Coco A, Epp SB, Crook JM. 2005. Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorinerual hearing loss. J Comp Neurol 486: 145-158.
85. Shepherd RK, Coco A, Epp SB. 2008. Neurotrophins and electrical stimulation for protection and repair of spiral ganglion neurons following sensorineural hearing loss. Hear Res 242: 100-109.
86. Shinohara T, Bredberg G, Ulfendahl M, Pyykko I, Olivius NP, Kaksonen R, Lindstrom B, Altschuler R, Miller JM. 2002. Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci U S A 99: 1657-1660.
87. Song BN, Li YX, Han DM. 2009. Delayed electrical stimulation and BDNF application following induced deafness in rats. Acta Otolaryngol 129: 142-154.
88. Spoendlin HH. 1969. Innervation patterns in the organ of Corti of the cat. Acta Otolaryngol 67: 239-254.
89. Spoendlin HH. 1975. Retrograde degeneration of the cochlear nerve. Acta Otolaryngol 79: 266-275.
90. Spoendlin HH. 1981. Differentiation of cochlear neurons. Acta Otolaryngol 91: 451-456.
91. Staecker H, Kopke R, Malgrange B, Lefebvre P, Van de Water TR. 1996. NT3 and BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 7: 889-894.
92. Staecker H, Gabaizadeh R, Rederoff H, Van de Water TR. 1998. Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol Head Neck Surg 119: 7-13.
93. Staecker H, Jolly C, Garnham C. 2010. Cochlear implantatin: an opportunity for drug development. Drug Disc Today 15: 314-321.
94. Stankovic K, Rio C, Xia A, Sugawara M, Aams JC, Liberman MC, Corfas G. 2004. Survival of adult spiral ganglion neurons requires erbB receptor signaling in the inner ear. J Neurosci 24: 8651-8661.
95. Svirsky MA, Robbins AM, Kirk KI, Pisoni DB, Miyamoto RT. 2000. Language development in profoundly deaf children with cochlear implants. Psychol Sci 11: 153-158.
96. Svirsky MA, Teoh SW, Neuburger H. 2004. Development of language and speech perception in congenitally, profoundly deaf children as a function of age at cochlear implantation. Audiol Neurotol 9: 224-233.
97. Turner CW, Reiss J, Gantz BJ. 2008. Combined acoustic and electric hearing: preserving residual acoustic hearing. Hear Res 242: 164-171.
98. Versnel H, Agterberg MJ, de Groot JC, Smoorenburg GF, Klis SF. 2007. Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide. Hear Res 231: 1-12.
99. Vieira M, Christensen BL, Wheeler BC, Feng AS, Kollmar R. 2007. Survival and stimulation of neurite outgrowth in a serum-free culture of spiral ganglion neurons from adult mice. Hear Res 230: 17-23.
100. Warnecke A, Wissel K, Hoffmann A, Hofmann N, Berkingali N, Gro G, Lenarz T, Stöver T. 2007. The biological effects of cell-delivered brain-derived neurotrophic factor on cultured spiral ganglion cells. Neuroreport 18: 1683-1686.
101. Wefstaedt P, Scheper V, Lenarz T, Stöver T. 2005. Brain-derived neurotrophic factor/glial cell line-derived neurotrophic factor survival effects on auditory neurons are not limited by dexamethasone. Neuroreport 16: 2011-2014.
102. Wise AK, Richardson R, Hardman J, Clark G, O'Leary S. 2005. Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J Comp Neurol 487: 147-165.
103. Yagi M, Kanzaki S, Kawamoto K, Shin B, Shah PP, Magal E, Sheng J, Raphael Y. 2000. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. JARO 1: 315-325.
104. Yamagata T, Miller JM, Ulfendahl M, Olivius NP, Altschuler RA, Pyykkö I, Bredberg G. 2004. Delayed neurotrophic treatment preserves nerve survival and electrophysiological responsiveness in neomycin-deafened guinea pigs. J Neurosci Res 78: 75-86.
105. Ylikoski J, Privola U, Virkkala, J, Suvanto P, Liang X-Q, Magal E, Altschuler RA, Miller JM, Saarma M. 1998. Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear Res 124: 17-26.
106. Zeng F-G, Rebscher S, Harrison WV, Sun X, Feng H. 2008. Cochlear implants: system design, integration and evaluation. IEEE Rev Biomed Eng 1: 115-142.
107. Zha XM, Bishop JF, Hansen MR, Victoria L, Abbas PJ, Mouradian MM, Green SH. 2001. BDNF synthesis in spiral ganglion neurons is constitutive and CREB-dependent. Hear Res 156: 53-68.
108. Zheng JL, Gao W-Q. 1996. Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur J Neurosci 8: 1897-1905.
109. Zheng JL, Stewart RR, Gao W-Q. 1995. Neurotrophin-4/5 enhances survival of cultured spiral ganglion neurons and protects them from cisplain ototoxicity. J Neurosci 7: 5079-5087.